Welcome!

News Feed Item

B Cell Study May Lead to Treatment Options for Progressive MS

MS Society of Canada and MS Scientific Research Foundation announce $3.6 million grant to understanding B cells for future MS therapies

TORONTO, ONTARIO -- (Marketwired) -- 02/18/14 -- The Multiple Sclerosis Society of Canada and the Multiple Sclerosis Scientific Research Foundation announced a $3.6 million grant to investigate the role of the B cell, a type of white blood cell of the immune system, in contributing to the development and propagation of multiple sclerosis. With collaboration between McGill University, Universite de Montreal and University of Toronto, world-leading MS experts Drs. Amit Bar-Or, Alexandre Prat and Jennifer Gommerman will engage in a unique interdisciplinary approach to identify and explain the role of B cells in MS.

To date, modern scientific understanding has considered MS to be a disease controlled by the T cell, another type of white blood cell. Research has shown that in MS, T cells mistakenly recognize and attack myelin, the protective layer of fat covering nerves in the central nervous system, exposing them to damage. Research in T cells has led to the development of therapies that aim to control or block the effects of harmful T cells.

However, a surprising discovery in emerging studies has revealed that therapies targeting B cells led to dramatic improvements in people living with MS. Moreover, B cells have recently been found in areas of the brain associated with progressive MS, which is a debilitating form of MS that currently has no treatments. These recent studies have led scientists to believe that B cells, which were previously overlooked in MS, are significant contributors to the disease.

"Based on the encouraging clinical trial results of B cell depletion in people with relapsing-remitting MS, the question is no longer whether B cells are important contributors to MS, but how they contribute," said Dr. Amit Bar-Or, clinician and scientist at the Montreal Neurological Institute at McGill University, and one of the study's lead investigators. "Members of our team have recently discovered that different types of human B cells exist. Some B cells promote inflammation, while others are actually able to limit inflammation. This collaborative study will allow us to address important emerging issues relevant to understanding and better treating MS, especially progressive MS."

"This funding provides a unique occasion to pool scientific resources and expertise from three major MS research centres in Canada to study the influence of B cells in the development of MS," said Dr. Alexandre Prat, neurologist and researcher at the Centre hospitalier de l'Universite de Montreal and professor at the Faculty of Medicine of Universite de Montreal. "It is truly an exciting moment for us, and for the MS community in general."

Drs. Bar-Or, Prat and Gommerman will collaborate to uncover fundamental knowledge about how B cells influence the course of MS. This information will point to clues about the cause of MS, while enabling them to explore the potential of B cell-targeted treatments for people living with all forms of MS.

"Our multi-centre team provides a large range of expertise, from clinical experience to extensive knowledge in immunology. Our collaborative research will accomplish our goal to learn more about B cells in MS, so that one day we could develop therapies for progressive forms of the disease," said Dr. Jennifer Gommerman, scientist and associate professor at the Faculty of Medicine of University of Toronto.

"As Canada has the highest rate of MS in the world, Canadian researchers have a special interest in finding new ways to think about the cause of MS and improve therapies for Canadians living with the disease," said Dr. Karen Lee, vice-president of research, MS Society of Canada. "We are excited that this research team is breaking new ground in the field of MS research that will further our knowledge about the complexity of MS. We believe that an end to MS is achievable, and this B cell study will bring us closer to finding the answers we need and ending MS."

"I think that finding the cause and cure for MS involves innovative thinking and ideas as well as working together to ultimately end this disease," said Andrea Butcher-Milne, who was diagnosed with MS in 1997. "It gives me comfort that researchers in our country are doing their best to realize the promise of a brighter future for people with MS."

This study has been selected by the Canadian Institutes of Health Research to be presented at this month's Cafe Scientifique held on February 18 in Toronto. Cafe Scientifique is an interactive series of presentations that allow scientists to share their research advances to the general public. For more details, visit the Cafe Scientifique website.

About multiple sclerosis and the MS Society of Canada

Canada has the highest rate of multiple sclerosis in the world. MS is a chronic, often disabling disease of the central nervous system comprising the brain, spinal cord and optic nerve. It is the most common neurological disease of young adults in Canada. Most people with MS are diagnosed between the ages of 15 and 40, and the unpredictable effects of MS last for the rest of their lives. The MS Society provides services to people with MS and their families and funds research to find the cause and cure for this disease. Please visit mssociety.ca or call 1-800-268-7582 to make a donation or for more information.

About the Multiple Sclerosis Scientific Research Foundation

The Multiple Sclerosis Scientific Research Foundation funds large, innovative, multi-centre collaborative studies that will lead to major advances in the field of multiple sclerosis. A unique Canadian resource, the Foundation's main funding source is the MS Society of Canada.

The Neuro

The Montreal Neurological Institute and Hospital - The Neuro, is a unique academic medical centre dedicated to neuroscience. Founded in 1934 by the renowned Dr. Wilder Penfield, The Neuro is recognized internationally for integrating research, compassionate patient care and advanced training, all key to advances in science and medicine. The Neuro is a research and teaching institute of McGill University and forms the basis for the Neuroscience Mission of the McGill University Health Centre. Neuro researchers are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of epilepsy, multiple sclerosis and neuromuscular disorders. For more information, visit theneuro.com.

About the Centre hospitalier de l'Universite de Montreal

The Centre hospitalier de l'Universite de Montreal (CHUM) first and foremost provides highly specialized healthcare in all medical specialties to a regional and supra-regional adult clientele. It is the main centre for development and knowledge transfer through its integrated activities in healthcare, teaching, research, assessment of technologies and treatment methods, as well as quality, the promotion of health and the patient experience. As of 2016, the CHUM will offer an improved hospital experience in its new downtown Montreal facilities. The CHUM is an active member of the Reseau universitaire integre de sante (RUIS) de l'Universite de Montreal. chumontreal.qc.ca

About the University of Toronto Faculty of Medicine

The University of Toronto Faculty of Medicine is at the heart of one of the great biomedical research, education and clinical care networks in the world. With nine fully affiliated hospitals and research institutes and 18 community-affiliated hospitals and clinical care sites, the Faculty of Medicine is a research powerhouse that offers unparalleled opportunities for its 6,800 faculty and 8,000-plus students at all levels. Nearly half of Ontario's medical doctors and fully 25 per cent of all health and biomedical PhDs in Canada were trained by the Faculty of Medicine, which consistently ranks among the top medical schools worldwide.

Contacts:
Lindsay Gulin
MS Society of Canada
416-922-6600 x3245
[email protected]

Isabelle Lavigne
Centre hospitalier de l'Universite de Montreal (CHUM)
514-890-8000 x15380
[email protected]

Anita Kar
Montreal Neurological Institute and Hospital
(The Neuro)
514-398-3376
[email protected]

Suniya Kukaswadia
Faculty of Medicine, University of Toronto
416-978-7752
[email protected]

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
In IT, we sometimes coin terms for things before we know exactly what they are and how they’ll be used. The resulting terms may capture a common set of aspirations and goals – as “cloud” did broadly for on-demand, self-service, and flexible computing. But such a term can also lump together diverse and even competing practices, technologies, and priorities to the point where important distinctions are glossed over and lost.
All clouds are not equal. To succeed in a DevOps context, organizations should plan to develop/deploy apps across a choice of on-premise and public clouds simultaneously depending on the business needs. This is where the concept of the Lean Cloud comes in - resting on the idea that you often need to relocate your app modules over their life cycles for both innovation and operational efficiency in the cloud. In his session at @DevOpsSummit at19th Cloud Expo, Valentin (Val) Bercovici, CTO of Soli...
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
Keeping pace with advancements in software delivery processes and tooling is taxing even for the most proficient organizations. Point tools, platforms, open source and the increasing adoption of private and public cloud services requires strong engineering rigor – all in the face of developer demands to use the tools of choice. As Agile has settled in as a mainstream practice, now DevOps has emerged as the next wave to improve software delivery speed and output. To make DevOps work, organization...
With major technology companies and startups seriously embracing IoT strategies, now is the perfect time to attend @ThingsExpo 2016 in New York. Learn what is going on, contribute to the discussions, and ensure that your enterprise is as "IoT-Ready" as it can be! Internet of @ThingsExpo, taking place June 6-8, 2017, at the Javits Center in New York City, New York, is co-located with 20th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry p...
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
Join Impiger for their featured webinar: ‘Cloud Computing: A Roadmap to Modern Software Delivery’ on November 10, 2016, at 12:00 pm CST. Very few companies have not experienced some impact to their IT delivery due to the evolution of cloud computing. This webinar is not about deciding whether you should entertain moving some or all of your IT to the cloud, but rather, a detailed look under the hood to help IT professionals understand how cloud adoption has evolved and what trends will impact th...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smar...
Internet of @ThingsExpo, taking place June 6-8, 2017 at the Javits Center in New York City, New York, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo New York Call for Papers is now open.
"ReadyTalk is an audio and web video conferencing provider. We've really come to embrace WebRTC as the platform for our future of technology," explained Dan Cunningham, CTO of ReadyTalk, in this SYS-CON.tv interview at WebRTC Summit at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Everyone knows that truly innovative companies learn as they go along, pushing boundaries in response to market changes and demands. What's more of a mystery is how to balance innovation on a fresh platform built from scratch with the legacy tech stack, product suite and customers that continue to serve as the business' foundation. In his General Session at 19th Cloud Expo, Michael Chambliss, Head of Engineering at ReadyTalk, discussed why and how ReadyTalk diverted from healthy revenue and mor...
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busin...
In an era of historic innovation fueled by unprecedented access to data and technology, the low cost and risk of entering new markets has leveled the playing field for business. Today, any ambitious innovator can easily introduce a new application or product that can reinvent business models and transform the client experience. In their Day 2 Keynote at 19th Cloud Expo, Mercer Rowe, IBM Vice President of Strategic Alliances, and Raejeanne Skillern, Intel Vice President of Data Center Group and G...